Boonstra Andre, Woltman Andrea M, Janssen Harry L A
Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Best Pract Res Clin Gastroenterol. 2008;22(6):1049-61. doi: 10.1016/j.bpg.2008.11.015.
Hepatitis B (HBV) and hepatitis C (HCV) viruses are the two major causes of chronic liver inflammation worldwide. Despite distinct virologic features, both viruses are preferentially hepatotropic, not directly cytopathic, and elicit liver diseases that share several aspects of their natural history. HBV and HCV infections also share some important features of the adaptive antiviral immune response. We describe the innate immune response in the early phase following infection, and how these early events may influence the development of the adaptive immune response in these two important viral infections. The mechanisms by which high levels of viral antigens, liver immunological features, the presence of regulatory T cells and impaired dendritic cell functions may maintain the HBV- and HCV-specific immunological failure, characteristic of chronic hepatitis B and C patients, are also evaluated.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)是全球慢性肝脏炎症的两大主要病因。尽管这两种病毒具有不同的病毒学特征,但它们均优先嗜肝,并非直接致细胞病变,且引发的肝脏疾病在自然史的多个方面具有共性。HBV和HCV感染在适应性抗病毒免疫反应方面也具有一些重要特征。我们描述了感染后早期阶段的固有免疫反应,以及这些早期事件可能如何影响这两种重要病毒感染中适应性免疫反应的发展。我们还评估了高水平病毒抗原、肝脏免疫学特征、调节性T细胞的存在以及树突状细胞功能受损可能维持慢性乙型和丙型肝炎患者所特有的HBV和HCV特异性免疫功能衰竭的机制。